Unilever wants the attractive cash flow and growth of GSK’s joint venture with Pfizer (4-6% is the aim for the GSK unit, though many think this is a tad ambitious). Unilever CEO Alan Jope is under pressure to grow the business after a lacklustre few years – a megadeal highlights the difficulty is fixing the […]









